Arun Jayant Sanyal
1,820 works · 163,688 citations · h-index 177
Top works
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- AGA technical review on nonalcoholic fatty liver disease
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
- Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- Mechanisms of NAFLD development and therapeutic strategies
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- The global NAFLD epidemic
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030